fashion -WSS

fashion

author：comprehensive 2025-09-29 13:46:12 - browse：62

Dozens of sickle cells in a whirlpool — coverage from STAT — Adobe

Nearly a decade ago, consultants delivered to Rodger Novak a kind of Sears catalog of human malady: 200 pages, listing dozens of different diseases, each annotated with — from a business standpoint — their best and worst attributes.

The document was supposed to help Novak, then the chief executive of CRISPR Therapeutics, navigate a pressing quandary. His company, along with two others, were founded to commercialize the new revolutionary gene-editing tool CRISPR-Cas9, which promised to cure numerous genetic diseases. But which should they target first? What was the best proof-of-concept?

“We looked at anything and everything,” said Novak, who stepped down as CEO in 2017 but remained on the board until this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Food as medicine: Medically tailored meals may get standardized

focus

WSS

General Catalyst, Summa Health deal will turn on physician buy

States should stop sabotaging methadone treatment reform

Supreme Court mifepristone arguments center on docs' right to sue

Primary care physicians play key roles in Alzheimer's management

The Readout: Lenmeldy, GLP

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

focus

fashion

leisure time

Heart attack and stroke risk calculators need revising

Eliminate the waiting period for sterilization covered by Medicaid

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Novo Nordisk to expand supply of Wegovy for U.S. patients

Continuity nursing helped my family in our darkest PICU moments

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

DIEP, the 'gold standard' of breast reconstruction, is under threat

Covid misinformation case heads to Supreme Court

Walensky prepares to leave CDC — and Congress — behind

Covid misinformation case heads to Supreme Court

focus

The Readout: Lenmeldy, GLP

Novo Nordisk to expand supply of Wegovy for U.S. patients

New Ultima Genomics DNA sequencer can read genome for $100

Even great ERs can’t make up for American health disparities

Congressmen charge Covid hearing ‘could have been an email’

Supreme Court mifepristone arguments center on docs' right to sue

focus

focus

Wikipedia

focus